ICD-10 coding for rare and complex conditions calls for advanced skills, precise documentation, and current guideline knowledge. FY 2026 updates add new codes and refined instructions that demand ...
US regulators are maintaining a cautious stance on using biomarkers as surrogate endpoints for drug approvals, even as 2026 ICD-10 coding rules tighten documentation standards. The FDA’s recent ...